TELA Bio (TELA) Equity Ratio (2018 - 2026)
TELA Bio's quarterly Equity Ratio came in at 0.07 in Q1 2026, down 131.72% year-on-year from 0.23 in Q1 2025, and down 195.97% quarter-over-quarter from 0.08 in Q4 2025.
TELA Bio has reported Equity Ratio for 9 years, with the latest figure at 0.07 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 131.72% year-over-year to 0.07; the trailing twelve-month figure through Mar 2026 stood at 0.07 (down 131.72% YoY), and the FY2025 full-year result was 0.08, down 76.41% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.07, down from 0.08 in the prior quarter.
- The five-year high for Equity Ratio was 0.42 in Q2 2023, with the low at 0.12 in Q3 2024.
- Average Equity Ratio over 5 years is 0.15, with a median of 0.18 recorded in 2022.
- Year-over-year, Equity Ratio soared 1510.97% in 2023 and slumped 133.81% in 2024.
- Tracing TELA's Equity Ratio over 5 years: stood at 0.21 in 2022, then climbed by 14.75% to 0.24 in 2023, then jumped by 35.89% to 0.33 in 2024, then sank by 76.41% to 0.08 in 2025, then sank by 195.97% to 0.07 in 2026.
- The last three Equity Ratio figures came in at 0.07 (Q1 2026), 0.08 (Q4 2025), and 0.03 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn | -0.07 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.07 |
| Dec 31, 2025 | 0.08 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.33 |
| Sep 30, 2024 | -0.12 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 0.20 |
| Dec 31, 2023 | 0.24 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.21 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | -0.03 |
| Mar 31, 2022 | 0.18 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.40 |
| Jun 30, 2021 | 0.47 |
| Mar 31, 2021 | 0.53 |
| Dec 31, 2020 | 0.57 |
| Sep 30, 2020 | 0.61 |
| Jun 30, 2020 | 0.65 |
| Mar 31, 2020 | 0.41 |
| Dec 31, 2019 | 0.46 |
| Sep 30, 2019 | -6.96 |
| Dec 31, 2018 | -5.06 |